Background: Robin sequence (RS) is a congenital disorder characterized by cleft palate,
The incidence of RS is reported to be between 1:8850 to 1:14 000 live births, based on data from national studies conducted in Germany and Denmark. 1, 2 The most recent study of RS epidemiology in the UK, published over 30 years ago, similarly reported RS incidence as 1 case per 8500 live births. 3 However, more recently data from USA and The Netherlands suggest that RS may be more common than previously suggested, with an estimated RS birth prevalence of 1 case per 3130-5600 live births reported. 4, 5 We hypothesized that the incidence of RS in the UK had increased since last reported. The study was designed to address this research question, and reports RS incidence in the East of Scotland (EoS) from 2004 to 2013. We also describe the airway management of infants with RS at our center, where a multidisciplinary team involving respiratory and cleft specialists adopt a shared care approach to RS management.
| MATERIALS AND METHODS
During the study period, the cleft service based at the Royal Hospital Treacher Collins Syndrome (n = 3) ( Table 1) .
A family history of cleft palate or other orofacial abnormality was present in 12 cases, and was more common in infants with RS+ (n = 7)
than isolated (n = 5) RS (P = 0.03). Prenatal diagnosis was rare;
antenatal ultrasound findings consistent with RS were identified in nine cases (micrognathia, n = 7; cleft palate, n = 2). Four children had risk factors for intrauterine compression (oligohydramnios, n = 2;
uterine fibroids, n = 1 twin pregnancy, n = 1). Excessive alcohol intake during pregnancy was reported in five cases, and drug misuse in eight cases (Methadone, n = 8; Diazepam, n = 6; misuse of ≥3 substances, n = 4). An additional four children were exposed to potentially teratogenic prescription medications in utero (Amitriptyline, n = 2;
Sodium valproate, n = 1 Misoprostol, n = 1). [TLA], n = 3), one of whom underwent tongue suture removal prior to hospital discharge and was subsequently managed with NPA.
A total of 64% infants with RS required feeding support with nasogastric feeds, and 7% (n = 7) required surgical feeding via gastrostomy or jejunostomy. All children who received surgical feeding support had RS+ (Table 2) .
| DISCUSSION
Our study found an incidence of RS of 1 case per 2685 live births, which remained stable across the 10-year study period. Our reported incidence is significantly higher than described by previous epidemiological studies.
This is the first population-based study of the incidence of RS in the United Kingdom since Bush and colleagues 3 reported a RS incidence of 1 in 8500 live births. Bush included infants with cleft palate who were hospitalized for at least 28 days with respiratory or feeding difficulties,
such that mild cases of RS may have been missed, a conclusion further supported by the high mortality rate (21%) which suggests a more severe RS phenotype than observed within our cohort. 3 Two landmark studies have since described RS incidence in other European countries. First, an incidence of 1 case of RS per 14 000 live births was reported by Printzlau and colleagues 2 from a 10-year Danish population-based study, using a national cleft palate registry Two further recent studies have pointed towards a higher RS incidence. Paes et al 4 reported an incidence of 1 in 5600 live births in the Netherlands, using the same case definition as Printzlau. They identified cases from two distinct data sources; the Dutch Cleft Registry, and case-note review of children with cleft palate admitted to three tertiary pediatric centers. Incidence was estimated as only 1 in 8600 before including cases identified from hospital records, indicating a risk of incidence underestimation when a cleft registry is the sole data source.
A yet higher incidence of 1 case per 3130 live births has been described in the USA, from a study which utilised a hospital admissions database (Kids' Inpatient Database; KID) 9 for case ascertainment. 5 RS was assumed in all cases where ICD-9 codes for micrognathia and cleft palate coexisted. The higher incidence described may be partly attributable to the broad case definition used, and partly to the omission of non-hospital births from denominator data. However, it should be noted that 77% of infants (406/529) underwent surgical airway management, suggesting that clinically significant UAO was present in the majority of cases and reducing the likelihood of substantial over-diagnosis.
Epidemiological studies of RS are limited by the widespread variability in diagnostic criteria used. 10 Such diagnostic inconsistency is illustrated by the various differing case definitions used in the above studies, and has been identified as a barrier to ascertainment of true incidence. Our chosen case definition of micrognathia, glossoptosis, and cleft palate, which is the definition most commonly used by medical professionals involved in RS management, 6, 7 is arguably more inclusive than criteria used in some previous studies. Inclusion of cleft palate was necessary for case identification, as an established registry for this patient group exists in our region and cases of missed cleft palate are rare. We chose to include infants without signs of respiratory distress at presentation as this can be a late or subclinical finding. [11] [12] [13] An Australian case series noted that UAO presented beyond 24 days of age in 7/10 infants with RS, and that 6/7 infants had faltering growth which normalized with alleviation of UAO. Thus, subclinical respiratory compromise may precede the onset of clinical symptoms. 13 The recent German surveillance study also noted faltering growth in association with undertreated UAO, with treatment of UAO resulting in improvement in weight SD scores. 1 There are several possible explanations for the higher incidence of RS identified by our study. RS incidence may have been underestimated in previous epidemiological studies due to undercounting, by omission of mild cases without overt UAO or need for hospital admission. [1] [2] [3] Recognition bias could potentially be a factor given that our cases were diagnosed by a single regional cleft service. However, over-diagnosis of RS in our cohort appears unlikely given the high prevalence of UAO symptoms (93%), which is similar to the UAO prevalence (89%) reported by Maas and Poets. 1 Confidence can also be taken from the fact that the majority of infants in our cohort received tertiary pediatric care, where assessment of UAO and decisions about airway management were overseen by a team of respiratory pediatricians. UAO assessments were made clinically, and in cases where clinical assessment was unclear or equivocal a sleep study (limited channel cardio-respiratory polygraphy) was carried out.
The requirement for active airway management in 63% of cases is comparable to reports from numerous studies of RS management across many different settings and populations, [14] [15] [16] [17] again suggesting that infants in our cohort had "true" and clinically significant RS.
The high incidence of RS could alternatively relate to a different risk factor profile in our population. The aetiology of RS is believed to be multifactorial, including a genetic predisposition and intrauterine exposure to compressive forces or environmental toxins. A family history of orofacial clefts was present in 12% of cases, increasing to 30% amongst infants with RS+, which is comparable to the 13-27%
reported by previous studies and supports a genetic contribution to aetiology. 18 Risk factors for intrauterine restriction of mandibular growth were present in 4%, and excessive maternal alcohol consumption in 5% cases. The most common antenatal drug exposure in our cohort was to Methadone, a maintenance therapy for opioid dependence. Published data from 2012/13 Scottish maternity records reports misuse of opioids (including prescribed Methadone) or multiple drug types in 1.6% of Scottish mothers. 19 Our finding that methadone was used by 8% mothers of infants with RS may therefore be seen as disproportionately high. Methadone has historically been considered as non-teratogenic. However, Cleary and colleagues recently identified an increased incidence of RS amongst infants with intrauterine Methadone exposure (1 in 155) compared with non-exposed (1 in 7552) infants (relative risk 48.8, 95% CI 14.7-161.9). This was substantially higher than the increased risk of non-RS orofacial clefts in Methadone exposed infants in the same population (relative risk 5.4, 95% CI 1.7-17.3; statistics derived from published data). 20 Of interest, a recently published national prevalence study of opioid use in pregnancy in Denmark (where RS incidence of 1:14 000 live births has been reported) identified opioid use in 0.06% of pregnancies which is substantially lower than amongst Scottish mothers. 21 The same study identified congenital malformations in 10.4% of methadone-exposed pregnancies which was higher than rates seen amongst non-exposed infants or those exposed to other opioid types. However, these apparent associations may not be due to Methadone-related teratogenicity and could equally be explained by confounding factors, for example differences between exposed and non-exposed mothers in terms of nutritional status, socioeconomic background, or rates of exposure to other potentially harmful substances (eg, alcohol or other illicit drugs).
Further research including well-designed prospective studies is needed investigate this association more definitively.
In our cohort, over half of infants were managed successfully with NPA, which is our first-line intervention for infants with evidence of moderate to severe UAO, as assessed either clinically or using cardio- There is heterogeneity of approach to management of UAO in RS, with no evidence-based clinical practice guidelines to direct management. 23 This lack of uniformity in approach was highlighted by a recent survey of practices across 101 European centers, which showed that NPA, CPAP, and palatal plates were strongly favored in the UK, France, and Germany, respectively. 7 Only 7% of our cohort required surgical airway management which concurs with the findings of recent large studies. 1 However, significantly higher rates of surgical intervention (including distraction osteogenesis and tongue-lip adhesion) and tracheostomy of 19-77% have been reported in several studies which are largely from North American centers. 5, [24] [25] [26] [27] This wide variation in practice with an apparent geographical pattern suggests that physician or treatment center preferences, rather than clinical necessity, may direct RS management.
In conclusion, we report RS incidence in the East of Scotland as 1:2685 live births, which is substantially higher than rates reported by previous UK epidemiological studies. Recognition bias is unlikely given the high prevalence of upper airway obstruction requiring active airway management. Possible explanations include an underestimation of RS incidence by previous studies due to omission of cases with subclinical UAO, or the presence of a different risk factor profile in our population.
A possible association between intrauterine Methadone exposure and RS development warrants further investigation. We are currently verifying and further investigating these findings through a UK-based national prospective surveillance study of RS incidence and management, in collaboration with the British Pediatric Surveillance Unit (BPSU), which commenced in January 2016.
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